# TERADYNE, INC. (TER) · Edgar & Edgarette company card

> Teradyne (TER) grew revenue 13.1% in FY2025 to $3.2 billion, operating margin 20.4% against a 12.5% median for instruments for meas & testing of  electricity & elec signals, equity 66.8% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 97210 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/TER) · [JSON](https://www.pops4.com/boards/company/TER.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $3.2B |
| Revenue growth, 1 year | 13.1% |
| Revenue growth per year | -3.7% |
| Operating margin | 20.4% (prior year 21.1%) |
| Net margin | 17.4% |
| Operating cash flow | $674M |
| Capital spending | $224M |
| Free cash flow | $450M |
| Cash | $294M |
| Long-term debt | — |
| Total assets | $4.2B |
| Total equity | $2.8B |
| Equity ÷ assets | 66.8% |
| Return on equity | 19.8% |
| Dividend per share | $0.48 |
| Dividend years rising | 0 |

## Readings, computed from those figures

- Altman Z: 5.05 (safe zone)
- Piotroski F: 6 of 9 (solid)
- Beneish M: -2.2 (below the −1.78 line)
- Health Harbor boat: Sound ship · one warning sign · slow and jumpy: growing slower than its size class, with revenue that swings more
- Cash Compass: In between · no clear cash pattern yet

## Edgarette's reading

Exposure: revenue $3.2B (FY2025). Experience: revenue up 13.1% on the year, down 3.7% a year over 4 years; operating margin 20.4%, down from 21.1%. Soundness: equity 66.8% of assets, return on equity 19.8%, payout 13.8% of profit. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $2.8B and $4.0B next year (method v4.1: its own 4-year record of growth weighed at 50% against $1B–10B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $2.4B to $4.5B. A statistical range, not company guidance. Against peers (41 filers, $50M+ revenue, its industry group): operating margin 20.4% against a 12.5% median; growth 13.1% against 3.8%.

Range logged 2026-09-26, receipt 3600e3d9475cff9f, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

No warning filings in the window.

## Recent filings

- 10-Q · filed 2026-10-30 · [filing](https://www.sec.gov/Archives/edgar/data/97210/000119312526441091/0001193125-26-441091-index.htm)
- 8-K · filed 2026-10-28 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/97210/000119312526434981/0001193125-26-434981-index.htm)
- 8-K · filed 2026-08-10 · 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/97210/000119312526342367/0001193125-26-342367-index.htm)
- 10-Q · filed 2026-07-31 · [filing](https://www.sec.gov/Archives/edgar/data/97210/000119312526327715/0001193125-26-327715-index.htm)
- 8-K · filed 2026-07-29 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/97210/000119312526321933/0001193125-26-321933-index.htm)
- 8-K · filed 2026-05-11 · 5.07 Submission of Matters to a Vote of Security Holders · [filing](https://www.sec.gov/Archives/edgar/data/97210/000119312526215848/0001193125-26-215848-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0000097210.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=97210

## Cite

POPS4, Edgar & Edgarette: TERADYNE, INC. (TER) company card, from the company's own SEC filings, accessed 2026-11-10, https://www.pops4.com/boards/company/TER. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.